tenecteplase
Selected indexed studies
- Tenecteplase vs Alteplase for Patients With Acute Ischemic Stroke: The ORIGINAL Randomized Clinical Trial. (JAMA, 2024) [PMID:39264623]
- Tenecteplase for Ischemic Stroke at 4.5 to 24 Hours without Thrombectomy. (N Engl J Med, 2024) [PMID:38884324]
- Tenecteplase Thrombolysis for Acute Ischemic Stroke. (Stroke, 2020) [PMID:33045929]
_Worker-drafted node — pending editorial review._
Connections
No connections recorded yet.
Sources
- Evolving Thrombolytics: from Alteplase to Tenecteplase. (2023) pubmed
- Tenecteplase vs Alteplase for Patients With Acute Ischemic Stroke: The ORIGINAL Randomized Clinical Trial. (2024) pubmed
- Tenecteplase for Ischemic Stroke at 4.5 to 24 Hours without Thrombectomy. (2024) pubmed
- Tenecteplase Thrombolysis for Acute Ischemic Stroke. (2020) pubmed
- Tenecteplase versus alteplase in acute ischaemic cerebrovascular events (TRACE-2): a phase 3, multicentre, open-label, randomised controlled, non-inferiority trial. (2023) pubmed
- Tenecteplase versus Alteplase before Thrombectomy for Ischemic Stroke. (2018) pubmed
- Comprehensive Review of Tenecteplase for Thrombolysis in Acute Ischemic Stroke. (2024) pubmed
- Tenecteplase for Stroke at 4.5 to 24 Hours with Perfusion-Imaging Selection. (2024) pubmed
- Tenecteplase versus alteplase for acute stroke within 4·5 h of onset (ATTEST-2): a randomised, parallel group, open-label trial. (2024) pubmed
- Tenecteplase in Acute Stroke: What About the Children? (2023) pubmed